Suppr超能文献

经导管动脉栓塞术治疗合并肝硬化的破裂肝细胞癌的疗效

Benefit of transcatheter arterial embolization for ruptured hepatocellular carcinoma complicating liver cirrhosis.

作者信息

Sato Y, Fujiwara K, Furui S, Ogata I, Oka Y, Hayashi S, Ohta Y, Iio M, Oka H

出版信息

Gastroenterology. 1985 Jul;89(1):157-9. doi: 10.1016/0016-5085(85)90756-5.

Abstract

In 6 patients with spontaneous rupture of hepatocellular carcinoma complicating liver cirrhosis, but with no occlusion of the main portal trunk, transcatheter arterial embolization was performed within 7 days of the rupture. All 6 patients were thought to be inoperable because of shock state or severe hepatic dysfunction. In all 6 patients, the progressive decrease in the hematocrit ceased soon after the embolization. Five patients survived for 31-168 days after the embolization; 1 patient who developed septicemia died 10 days later. We conclude that transcatheter arterial embolization is beneficial as a procedure of first choice for ruptured hepatocellular carcinoma when the portal blood flow is maintained.

摘要

6例肝细胞癌自发性破裂并发肝硬化但主门静脉未闭塞的患者,在破裂后7天内进行了经导管动脉栓塞术。所有6例患者因休克状态或严重肝功能障碍被认为无法手术。所有6例患者在栓塞术后不久,血细胞比容的进行性下降停止。5例患者在栓塞术后存活31 - 168天;1例发生败血症的患者在10天后死亡。我们得出结论,当门静脉血流保持时,经导管动脉栓塞术作为破裂肝细胞癌的首选治疗方法是有益的。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验